Individualised Therapeutics and Monitoring
Select, dose, monitor and stop medicines using indication, evidence, organ function and patient context.
How to prepare for MRCP(UK) Part 2 Written
Use the official likely question distribution to protect breadth, then practise extracting decisive clinical and visual evidence before selecting one best answer.
Core concepts
Concept 1
Indication, expected benefit, allergy, interaction, renal or hepatic function, therapeutic window and patient priorities.
Exam cue: A medicine causing haemodynamic, neurological, metabolic, bleeding or organ-threatening toxicity.
Concept 2
Choose the safest effective medicine and dose, define monitoring and review, and deprescribe when net benefit is lost.
Exam cue: Use baseline risk, therapeutic drug monitoring when valid, organ-function trends and response measures that can change treatment.
Risk pitfalls and guardrails
Continuing a copied prescription without reconciling current physiology, indication and interactions.
Guardrail: Do not interpret a visual pattern without the modality, clinical context and the exact task in the stem.
Selecting an option that is true in isolation but does not best answer the exact clinical task.
Guardrail: Do not interpret a visual pattern without the modality, clinical context and the exact task in the stem.
Memory anchors
What frames Individualised Therapeutics and Monitoring?
Indication, expected benefit, allergy, interaction, renal or hepatic function, therapeutic window and patient priorities.
Which individualised therapeutics and monitoring findings change urgency?
A medicine causing haemodynamic, neurological, metabolic, bleeding or organ-threatening toxicity.
How should investigations be chosen in individualised therapeutics and monitoring?
Use baseline risk, therapeutic drug monitoring when valid, organ-function trends and response measures that can change treatment.
What guides management in individualised therapeutics and monitoring?
Choose the safest effective medicine and dose, define monitoring and review, and deprescribe when net benefit is lost.
What common error should be avoided in individualised therapeutics and monitoring?
Continuing a copied prescription without reconciling current physiology, indication and interactions.
Checkpoint rule
Do the check-up only after you can summarize each concept in one sentence and identify one dangerous pitfall from memory.
Knowledge Check (after reading)
Short check-up to confirm understanding of this module.
Check-up Questions
An 84-year-old woman taking digoxin for atrial fibrillation develops nausea, confusion and yellow vision after dehydration-induced AKI. ECG shows slow AF with ventricular ectopy. What is the priority?
A 70-year-old man stable on lithium develops vomiting and starts ibuprofen while continuing ramipril. He becomes ataxic and confused. What is the most appropriate investigation and action?
Answer all questions to submit.
Next step personalized recommendations
Continue learning
Move forward only after this module is stable.
What is Pass Harbor?
Completely free exam prep for 247 UK exams.
- Practice questions
- Flashcards
- Study guides
- Mock exams
- No registration
- No paywall
- Start instantly
“No more expensive exam prep. Quality study tools should be accessible to everyone.”